Gordon McCauley was appointed President and CEO of CDRD in 2017 after serving on the Board for four years. Mr. McCauley is an accomplished life science investor and executive.
He has served as President & CEO of Viable Healthworks Corp., a national healthcare service business; President and CEO of Allon Therapeutics Inc., a neuroscience biotechnology company that developed novel therapeutics from pre-clinical to global phase 3 studies before being sold, and Co-Founder and Partner of NDI Capital, an institutionally-backed life-science investment fund. Mr. McCauley has also been a senior executive of several successful health care enterprises and a senior advisor to several prominent Canadian political leaders.
Mr. McCauley is a Director of Defender Therapeutics, Inc., and 3D Signatures Inc. He is also a Director of LifeSciences British Columbia and served as its Chair from 2012 – 2015, and a Director of BioteCanada. In 2008 Mr. McCauley was the first Canadian appointed to the Board of The Biotechnology Industry Organization (BIO) in Washington D.C., where he served in leadership positions until 2013. He is Past Chair of Acetech, and was a founding Director of the Toronto Rehabilitation Institute and Past Chair of the Toronto Rehab Foundation.